among the many complications of hcv treatment that must be managed efficiently and effectively are depression and other psychiatric disorders; hematologic abnormalities including daa- and ribavirin-associated anemia and peginterferon alfa-associated neutropenia and thrombocytopenia; rash and drug eruptions, including telaprevir-associated rash; and weight loss.